BIOGEN INC (BIIB) Stock Institutional Trading Activity


BIOGEN INC (BIIB) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Renaissance Technologies LLC, Causeway Capital Management, Sequoia Financial Advisors, Hillman Value Fund, and Parnassus Endeavor Fund. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2017Muhlenkamp & CoBuy13524,682$7,863
Q4 2017Mairs & Power Growth FundSell-281,025$327
Q4 2017Hancock Classic ValueBuy172931$297
Q4 2017ARK InvestBuy2,3116,579$2,096
Q4 2017Sequoia Financial AdvisorsBuy61413,896$4,427
Q3 2017Muhlenkamp & CoSell-99824,547$7,686
Q3 2017ARK InvestBuy1,3284,268$1,336
Q3 2017Sequoia Financial AdvisorsBuy73813,282$4,159
Q3 2017Renaissance Technologies LLCSell-642,700120,161$37,625
Q2 2017Muhlenkamp & CoBuy74125,545$6,932
Q2 2017Mairs & Power Growth FundBuy281,053$286
Q2 2017ARK InvestSell-3682,940$798
Q2 2017Sequoia Financial AdvisorsBuy1,23312,544$3,404
Q2 2017Renaissance Technologies LLCSell-86,100762,861$207,010
Q1 2017Muhlenkamp & CoBuy1,52524,804$6,782
Q1 2017Hancock Classic ValueBuy117759$208
Q1 2017ARK InvestSell-353,308$904
Q1 2017Sequoia Financial AdvisorsBuy1,15711,311$3,093
Q1 2017Viking Global InvestorsSell-1,230,047688,765$188,322
Q1 2017Renaissance Technologies LLCBuy141,466848,961$232,123
Q4 2016Muhlenkamp & CoSell-19923,279$6,601
Q4 2016ARK InvestBuy3,3433,343$948
Q4 2016Sequoia Financial AdvisorsBuy10,15410,154$2,879
Q4 2016First Eagle U.S. ValueSell-200,235257,025$72,887
Q4 2016Renaissance Technologies LLCBuy469,234707,495$200,631
Q4 2016Viking Global InvestorsSell-267,5241,918,812$544,137
Q3 2016Muhlenkamp & CoSell-22523,478$7,349
Q3 2016Hancock Classic ValueBuy642642$201
Q3 2016Renaissance Technologies LLCBuy197,861238,261$74,583
Q3 2016Causeway Capital ManagementSell-84,819404,444$142,206

Frequently asked questions about BIIB activity

  • Which institutional owners are buying BIIB?

    Institutional owners buying BIIB include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in BIIB activity?

    "Buy" means an investor increased their reported position in BIIB compared to the prior reporting period. This reflects growing exposure to BIOGEN INC (BIIB) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in BIIB increasing?

    Institutional interest in BIIB can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.